Xenetic Biosciences, Inc. stock is up 8.14% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 11 December’s closed higher than November.
Xenetic Biosciences, Inc. focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology. The company has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC.